Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (121-130 of 778) with videos related to

Pageof 78
Sort By:
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|January 4, 2020
Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?Davide Capodanno, Dominick J Angiolillo
Circulation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Upcoming TAVI trials: rationale, design and impact on clinical practiceDavide Capodanno, Martin B Leon
JACC. Cardiovascular Interventions|July 25, 2020
Stent Wars: Coated Stents Strike BackDavide Capodanno, Marco Angelo Monte
Expert Review of Clinical Pharmacology|December 28, 2024
Gene therapy in cardiology: pioneering a new era in medical ethics and patient careMaria Sara Mauro, Davide Capodanno
Thrombosis and Haemostasis|February 24, 2025
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding RiskMaria Sara Mauro, Davide Capodanno
The New England Journal of Medicine|January 22, 2025
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XIDominick J Angiolillo, Davide Capodanno
Journal of the American College of Cardiology|June 12, 2012
Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitorsDominick J Angiolillo, Davide Capodanno
Pageof 78

Showing results (121-130 of 778) with videos related to

Sort By:
Pageof 78
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|January 4, 2020
Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?Davide Capodanno, Dominick J Angiolillo
Circulation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Journal of Thoracic Disease|December 23, 2017
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Islam Y Elgendy, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Upcoming TAVI trials: rationale, design and impact on clinical practiceDavide Capodanno, Martin B Leon
JACC. Cardiovascular Interventions|July 25, 2020
Stent Wars: Coated Stents Strike BackDavide Capodanno, Marco Angelo Monte
Expert Review of Clinical Pharmacology|December 28, 2024
Gene therapy in cardiology: pioneering a new era in medical ethics and patient careMaria Sara Mauro, Davide Capodanno
Thrombosis and Haemostasis|February 24, 2025
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding RiskMaria Sara Mauro, Davide Capodanno
The New England Journal of Medicine|January 22, 2025
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XIDominick J Angiolillo, Davide Capodanno
Journal of the American College of Cardiology|June 12, 2012
Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitorsDominick J Angiolillo, Davide Capodanno
Pageof 78